Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer
88 μM) suggests an ability to overcome drug resistance in ovarian cancer
InChiKey: NJXWZWXCHBNOOG-UHFFFAOYSA-N
InChi: InChI=1S/C16H15ClO6/c1-8(18)22-13-11-6-5-10(17)7-12(11)14(23-9(2)19)16(21-4)15(13)20-3/h5-7H
Hodivala-Dilke K
SBI-0640756 idotoxin TFA Randomized phase III study ofSBI 0640756 (SBI 756) is an inhibitor of eIF4G1 and disrupts the eIF4F complex. Product information CAS Number: 1821280 29 8 Molecular Weight: 404. 82 Formula: C23H14ClFN2O2 Chemical Name: 6 chloro 3 [(2E) 3 (5 fluoropyridin 3 yl)prop 2 enoyl] 4 phenyl 1,2 dihydroquinolin 2 one Smiles: O=C1NC2C=CC(Cl)=CC=2C(=C1C(=O) C=C C1C=NC=C(F)C=1)C1C=CC=CC=1 InChiKey: VVWGPQZBDQVQRC RMKNXTFCSA N InChi: InChI=1S C23H14ClFN2O2 c24 16 7 8 19 18(11 16)21(15 4 2 1 3 5
US$ 36.00
US$ 59.00
US$ 55.00
US$ 75.00
US$ 10.00
US$ 26.00
US$ 156.00
US$ 46.00